American Journal of Hematology.
British Journal of Haematology. Biology of Blood and Marrow Transplantation. Journal of Thrombosis and Haemostasis.
Radiotherapy and Oncology. Thrombosis and Haemostasis. Transfusion Medicine Reviews.
Bone Marrow Transplantation. Current Opinion in Hematology.
Pediatric Blood and Cancer. Experimental Hematology.
Stem Cells and Development. Leukemia Research and Treatment. Acta Oncologica.
Extraordinary' new cancer drug appears to cure a third of. It may help guide therapy and future studies. Alternative cancer treatments in Mexico Holistic Bio Spa. Home News From the Blood Journals. Rejecting cancer treatment: What are the consequences. Preclinical research conducted at Weill Cornell Medicine demonstrated that sustained inhibition of CDK4 a protein that promotes growth of MCL cells by the oral drug palbociclib can not only prevent proliferation of MCL cells, but also make them more sensitive to attack by ibrutinib.
Seminars in Thrombosis and Hemostasis. International Journal of Clinical Oncology. Current Hematologic Malignancy Reports.
Journal of Clinical Apheresis. Annals of Hematology.
Today, imbalances between aggregate supply and demand are a major challenge in blood markets, including excess supply after disasters and insufficient supply at other times. These imbalances are not unexpected given that the blood market operates without market prices and with limited storage length about six weeks for whole blood.
Yet shifting to a system of paying blood donors seems a practical impossibility given attitudes toward paying blood donors and concerns that a paid system could compromise blood safety. Nonetheless, we believe that an economic perspective offers promising directions to increase supply and improve the supply and demand balance even in the presence of volunteer supply and with the absence of market prices. DOI: One thing I'd hoped to learn from this article was the size of the profits in the blood business, and how it compares with the various costs.
Prices are contracted and hence do not typically change with short-term fluctuations in supply or demand; only 12 percent of US hospitals report prices increasing during periods of shortage. It wasn't clear from the article how valuable plasma is compared to whole blood.
A weekly snapshot of the hottest studies from Blood, the official journal of the American Society of Hematology (ASH), hand-picked from each issue by the editors. Archive of all online content. January 01, - October 03, Show Covers ? Browse by Volumes · s · s · s · s · s · s · s.
One thing that goes unmentioned in the Titmuss discussions is the possibility of donor unhappiness with deceptive practices. The Red Cross does not publicize the profits it makes by selling blood.